Business
Bluebird Bio Inc.'s Gene Therapy for a Brain-wasting Disease Received Accelerated ... - Latest Tweet by Bloomberg
The latest Tweet by Bloomberg states, 'Bluebird Bio Inc.’s gene therapy for a brain-wasting disease received accelerated approval from U.S. regulators, making it the first treatment ...'
Bluebird Bio Inc.’s gene therapy for a brain-wasting disease received accelerated approval from U.S. regulators, making it the first treatment https://t.co/EWu1mixfqV— Bloomberg (@business) September 17, 2022
(The above story first appeared on LatestLY on Sep 17, 2022 10:29 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
